The impact of lowering prescription drug prices

For all the polarization in American politics, one thing both sides of the aisle seem to agree on -- prescription drug prices are too high. Kirsten Axelsen a former Pfizer executive and now a visiting fellow at the American Enterprise Institute, joined The Final Round to discuss why she thinks the current system is flawed, but that proposed legislation from the democrats will curtail investment in new therapies.